Sharon Shacham, President & CSO at Karyopharm Therapeutics Inc. (KPTI), sold 12,500 shares at $10.23 ($128K) on 2019-01-07, disclosed to the SEC on 2019-01-09.
Open-market sale of $128k KPTI by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |
| KPTI | SELL | 2021-03-23 | $50K | — | Filing → |
| KPTI | SELL | 2021-02-22 | $282K | — | Filing → |